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S2Objective: To evaluate the effectiveness and outcomes of an intraoperative and postoperative algorithm for
managing systolic anterior motion (SAM) after mitral valve repair (MVRr).
Methods: All consecutive patients who underwent MVRr for degenerative disease from January 2002 to June
2011 were included, with the data collected retrospectively. Patients who underwent MVRr for primary SAM
were excluded from the study. Patients who developed SAM after the repair were systematically treated accord-
ing to the algorithm. The intraoperative algorithm first involved medical management techniques, followed by
surgical correction for significant SAM (mild or greater mitral regurgitation, left ventricular outflow tract gra-
dient>50 mm Hg). The postoperative algorithm focused on medical management and symptoms to guide the
treatment decisions.
Results: The overall in-hospital incidence of SAMwas 6.6% (52/785). In 41 patients, SAMwas identified in the
operating room, and in 11 patients, it was found postoperatively on the predischarge echocardiogram. Of the 41
patients with intraoperative SAM, 35 (85.4%) had resolution with medical management and 6 (14.6%) required
surgical repeat repair while in the operating room. No patient required mitral valve replacement for persistent
SAM. Postoperatively, 11 new cases were identified, and 7 cases of resolved intraoperative SAM recurred. These
postoperative cases of SAMwere managed according to the postoperative SAM algorithm. At last follow-up, 17
(94.4%) of 18 patients had resolution of SAM and 1 (5.6%) patient had mild SAM (less than mild mitral re-
gurgitation, peak left ventricular outflow tract gradient< 50 mm Hg) and were asymptomatic. No patients
with postoperative SAM required reoperation after their initial surgery. The median echocardiographic
follow-up was 1.3 years. During follow-up, 1 early death (noncardiac) and 2 late deaths (1 noncardiac, 1 of un-
known etiology) occurred.
Conclusions: SAM is a relatively frequent complication after MVRr and can occur intraoperatively or postop-
eratively. A systematic approach addressing perioperative SAM after MVRr yields excellent mid-term results.
(J Thorac Cardiovasc Surg 2012;143:S2-7)In the current era of mitral valve repair (MVRr), systolic
anterior motion (SAM) of any severity occurs in 4% to
10% of cases.1,2 The degree of SAM after MVRr can
vary from mild to severe and is typically associated with
mitral regurgitation (MR) with left ventricular outflow
tract (LVOT) obstruction. Despite a number of
techniques designed to avert SAM, it still occurs at
a significant incidence, requiring surgeons to be
cognizant of its possibility and approaches to managinge Department of Cardiothoracic Surgery, Mount Sinai Medical Center, New
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The Journal of Thoracic and Cardiovascular Surgeit. Although most cases of SAM resolve with medical
management, situations exists in which a patient requires
early or delayed reoperation for SAM, making this an
issue that mitral valve surgeons should be comfortable
treating.2 Aside from the basic medical approach to the
management of SAM, knowing when to intervene perio-
peratively has not been clear. We believe that with an ap-
propriate algorithm for the perioperative management of
SAM, one can be better equipped to systematically address
the problem and know when and how to intervene. We
provide a review of SAM, followed by our algorithm for
the management of SAM and our results using this
algorithm.SAM: WHAT IS IT?
SAM is defined as displacement of the distal portion of
the anterior leaflet of the mitral valve toward the LVOT dur-
ing systole.3 The primary lesion resulting in SAM after
MVRr is a mismatch between the mitral valve annular di-
mension and the amount of leaflet tissue present. A number
of mechanisms have been described to account for SAMry c April 2012
Abbreviations and Acronyms
LVOT ¼ left ventricular outflow tract
MR ¼ mitral regurgitation
MVRr ¼ mitral valve repair
SAM ¼ systolic anterior motion
Varghese et al Mitral Valve Prolapsewith the 2 most predominant mechanisms being the ‘‘ven-
turi effect’’ and the ‘‘drag effect.’’ Both mechanisms
describe the anterior leaflet being drawn into the outflow
tract either by a pulling (venturi) or pushing (drag) phenom-
enon.4 As the left ventricle contracts and ejects blood
through the outflow tract and into the aorta, it creates drag
(push) on redundant anterior leaflet tissue, drawing the tip
of the anterior leaflet into the outflow, creating turbulence
to flow that further creates a venturi (pulling) effect on the
anterior leaflet and the potential for MR. This mechanism
for SAM typically occurs secondary to MVRr for degener-
ative disease. SAM can also occur primarily in cases of hy-
pertrophic cardiomyopathy, in which a thickened left
ventricular septum in addition to abnormal chordal attach-
ments to the anterior leaflet in the presence of a hypertro-
phied and hyperdynamic ventricle can result in SAM. In
this case, the drag phenomenon is believed to play a larger
role than the venturi effect. In the present report, we have
focused on SAM that occurs secondary to MVRr surgery
for degenerative disease.
A number of risk factors exist that predispose a patient to
SAM. These can be divided into patient factors and techni-
cal factors related to the repair. Patient risk factors include
a narrow aortomitral angle, a bulging left ventricular sep-
tum, and a hyperdynamic small left ventricle.5 Technical re-
pair factors include excessive posterior leaflet tissue (>15
mm) and an annuloplasty ring that is undersized relative
to the size of the anterior leaflet.6METHODS
From January 2002 to June 2011, 785 consecutive patients who under-
went MVRr for degenerative disease were included. Data were collected in
a retrospective manner. Patients with primary systolic anterior motion as
a result of hypertrophic obstructive cardiomyopathy or previous mitral
valve surgery were excluded. Patients who underwent concomitant tricus-
pid valve repair or concomitant coronary artery bypass surgery were in-
cluded. Intraoperatively and postoperatively, the patients who developed
SAMwere treated according to a prespecified SAMmanagement algorithm
(Figures 1 and 2). Intraoperatively, SAM was diagnosed by cardiac
anesthesiologists certified in echocardiography and was defined as any
portion of the anterior leaflet prolapsing into the LVOT. The degree of
SAM was classified into 2 categories: mild SAM (LVOT gradient< 50
mm Hg and/or less than mild MR) and significant SAM (LVOT gradient
>50 mm Hg and/or mild MR or greater). A number of repair techniques
were used to repair the mitral valve, including leaflet resection, leaflet
sliding plasty, and placement of neochordae. All patients had either a full
or partial annuloplasty ring placed. All patients were followed up with
serial echocardiography and clinical evaluation by our team and
subsequently by the patient’s cardiologist. Patients found to haveThe Journal of Thoracic and Casignificant SAM postoperatively were treated according to the algorithm
and underwent serial echocardiograms until resolution of significant
SAM was evident.
Algorithm for SAM
Managing SAM perioperatively requires a systematic approach to the
problem (Figure 1). Intraoperatively, minimizing the risk of SAM begins
with technically adequate repair. This includes ensuring that the posterior
leaflet height above the coaptation zone is not excessively tall (>15 mm)
and that the annuloplasty ring is appropriately sized. In cases of posterior
leaflet resection, a sliding leaflet technique can be used to shorten the pos-
terior leaflet height.7 We also use the intraoperative ‘‘ink-test’’ to assess the
coaptation depth of the anterior leaflet.8
If SAM is seen initially when weaning from bypass, our recommenda-
tion is to first use the medical interventions listed in the algorithm to opti-
mize the physiology. If persistent SAM is present, the degree of SAM and
the structural appearance of the valve on echocardiography is important. If
the posterior or anterior leaflet tissue is clearly excessive, regardless of the
response to medical interventions, we would have a low threshold for re-
suming bypass and surgical correction because the patient will likely re-
main with a substrate for future SAM. In young patients, especially those
who had asymptomatic MR, we have a very low threshold for surgical cor-
rection of SAM, irrespective of the response to medical interventions. If
mild SAM is present, defined as less than mild MR and a LVOT gradient
of less than 50 mm Hg, we usually use no additional surgical intervention
and proceed to reversal of heparin and decannulation. An echocardiogram
should be done before hospital discharge to confirm the SAM does not re-
cur or worsenwhen the patient is ambulatory. If the SAM is physiologically
significant, defined as mild MR or greater and/or a LVOT gradient greater
than 50 mm Hg, we recommend reinstituting cardiopulmonary bypass and
performing surgical repair.
Managing SAM that is discovered after the patient has left the operat-
ing room, but before discharge, is more challenging and requires a more
conservative approach (Figure 2). If mild SAM is present with less than
mild MR and a LVOT gradient of less than 50 mm Hg, we would increase
the dosage of oral b-blockers as tolerated and avoid the use of diuretics
and antihypertensive agents for systolic blood pressure less than 135
mm Hg. If improved the patient would be discharged with a repeat
echocardiogram at the patient’s routine follow-up appointment in 6
weeks. If the SAM results in more than mild MR or a LVOT gradient
greater than 50 mm Hg exists, we would institute the above-stated med-
ical treatments and repeat the echocardiogram in 48 hours. If resolved,
again, the patient would be discharged home with a follow-up examina-
tion within 6 weeks.
If, however, the repeat transthoracic echocardiogram reveals persistent
SAMwith more than mild MR and/or a LVOT gradient greater than 50 mm
Hg, one should consider early reoperation according to the symptoms, se-
verity of excess leaflet tissue prolapsing into the LVOT, and the patient’s
comorbidities. In these patients, we invariably discharge them home with
medical therapy and perform a repeat transthoracic echocardiogram within
2 to 6 weeks. If the SAM is still significant, we would recommend elective
reoperation if the patient is without major comorbidities.RESULTS
The overall incidence of SAM after MVRr was 6.6%
(52/785). The types of valve dysfunction are listed in
Table 1. The repair techniques varied, and a lesion-
specific approach was used to address the various
pathologies.9
Of the 52 patients with SAM, 41 (78.8%) were identified
in the operating room, and 11 new (not identified intraoper-
atively) cases (21.2%) were identified on the predischargerdiovascular Surgery c Volume 143, Number 4S S3
FIGURE 1. Management of intraoperative systolic anterior motion.
Mitral Valve Prolapse Varghese et alechocardiogram. Using intraoperative medical therapy (in-
creased mean arterial pressure, slow heart rate, increased
preload, and avoidance of inotropes) 35 (85.3%) of 41 pa-
tients with intraoperative SAM had resolution or the SAM
was downgraded to mild, hence not requiring additional in-
traoperative intervention. Despite intraoperative medical
therapies, 6 (14.7%) of the 41 patients had persistent signif-
icant SAM after discontinuation of cardiopulmonary by-
pass. In these 6 patients, surgical repeat repair of the
valve was performed during the same operation. The details
of these 6 patients’ initial repair and the repeat repair tech-
niques used to address SAM are listed in Table 2. In all
cases of repeat repair, shortening of the posterior leaflet
height was performed, in addition to other techniques. In
those patients who required surgical repeat repair during
the same operation for SAM—all cases of significant
SAM resolved after repeat repair was performed. No patient
required mitral valve replacement for persistent and signif-
icant SAM. The patients who developed SAM intraopera-
tively were identified, and their postoperative care was
altered to ensure adequate medical management was insti-
tuted postoperatively to avoid worsening or recurrence of
SAM. Higher mean arterial pressures (75–90 mm Hg)
were allowed, b-blocker therapy was instituted when possi-
ble, and aggressive diuresis was avoided during the pa-
tients’ recovery.S4 The Journal of Thoracic and Cardiovascular SurgePostoperatively, all patients underwent a predischarge
echocardiogram between postoperative day 3 and the day
of discharge. Of the 35 patients with intraoperative SAM,
7 showed recurrence on the predischarge echocardiogram.
These patients were all asymptomatic at the time. The post-
operative aspect of the SAM algorithm was then instituted
for these patients. Of these 7 patients, 1 case involved a pa-
tient who had already undergone surgical intraoperative re-
peat repair for SAM (patient 6 listed in Table 1) during the
initial operation. The LVOT gradient on the predischarge
echocardiogram was measured at 52 mm Hg with mild
MR. After continued medical management and avoidance
of diuretics, the SAM resolved, with an LVOT gradient of
10 mm Hg and minimal MR noted. The other 6 patients
who developed recurrent SAM were treated medically and
5 showed resolution before discharge, with resolution re-
maining at the last follow-up visit. In 1 case, significant
SAM was noted at discharge. The patient was 51 years
old, asymptomatic, and ambulating well. His predischarge
echocardiogram revealed a hyperdynamic left ventricle
with an ejection fraction estimated at 75%. He was dis-
charged homewith close follow-up and returned for a repeat
echocardiogram 3 weeks later. That echocardiogram
showed resolution of the SAM, with no MR or LVOT ob-
struction. His left ventricle was also no longer
hyperdynamic.ry c April 2012
FIGURE 2. Management of postoperative systolic anterior motion.
Varghese et al Mitral Valve ProlapseIn addition to these 7 recurrent cases of SAM, 11 new
cases of SAM were identified postoperatively. These
were patients in whom SAM was not reported intraopera-
tively by the cardiac anesthesiologist. These patients were
also treated according to the SAM algorithm. In 9 (81.8%)
of 11 cases, SAM resolved before discharge with medical
therapy. In 2 patients, significant SAM persisted on the
predischarge echocardiogram despite medical therapy.
Both patients were younger (age 49 and 60 years) and,TABLE 1. Leaflet pathology and repair techniques
Variable n (%)
Pathology
Posterior leaflet dysfunction 45 (86.5)
Anterior leaflet dysfunction 3 (5.8)
Bileaflet leaflet dysfunction 4 (7.7)
Repair technique
Posterior leaflet 44 (84.6)
Isolated posterior resection 15 (28.8)
Posterior resection with neochordae 7 (13.5)
Posterior resection with sliding plasty
with or without neochordae
22 (42.3)
Anterior leaflet 4 (7.7)
Anterior leaflet triangular resection 2 (3.9)
Chordal transfer/neochordae 2 (3.9)
Bileaflet 4 (7.7)
Posterior resection with sliding and
neochordae to anterior/posterior leaflet
4 (7.7)
The Journal of Thoracic and Camost importantly, were asymptomatic and ambulating
without issue. Both patients underwent predischarge echo-
cardiograms documenting hyperdynamic left ventricular
function. On return follow-up within 6 weeks repeat echo-
cardiogram revealed resolution of the SAM with no
LVOT obstruction and their ventricles were no longer
hyperdynamic.
At a mean echocardiographic follow-up of 1.3 years, no
cases of significant SAM were identified. Only 1 case of
mild SAMwas identified. This was identified on echocardi-
ography 3 years after surgical repair in an 83-year-old (age
at follow-up) male patient who had mild SAM intraopera-
tively and postoperatively with a LVOT gradient less than
50 mm Hg and no MR. At 3 years of follow-up, he was
asymptomatic and the LVOT gradient was 27 mm Hg
with no MR. Of note, his septum had increased in thickness
from 15 mm on his predischarge echocardiogram to 23 mm
and his left ventricle was noted to be hyperdynamic with an
ejection fraction estimated at 87%.
During the follow-up period, there was 1 early death
(noncardiac) and 2 late deaths, 1 of cardiac etiology and 1
of unknown etiology.DISCUSSION
SAM creates a difficult management problem when ob-
served after MVRr for degenerative disease. If it resolves
intraoperatively with medical management, one is often
reassured that the patient will be fine postoperatively. It isrdiovascular Surgery c Volume 143, Number 4S S5
TABLE 2. Details of 6 patients requiring intraoperative repeat repair for systolic anterior motion
Pt.
no. Etiology of MR Valve lesion Initial repair technique Ring type and size Repeat repair technique
SAM
resolution
1 Barlow’s disease Ruptured A2 chord,
restricted calcified P3
chord
Triangular resection of
A2, annuoplasty ring
C-E Physio 40 mm Posterior leaflet
shortening by
horizontal resection at
annulus
Yes
2 Barlow’s disease P3 chordal elongation P3 resection and sliding
plasty
C-E Physio 38 mm P1 shortening by
horizontal resection at
annulus
Yes
3 Forme fruste P2 chordal elongation P2 triangular resection C-E Physio 32 mm Triangular resection of A2
tip and cutting of
abnormal chord; P2
Gore-Tex chord to
lower height
Yes
4 Forme fruste P2 chordal elongation P2 quad resection,
horizontal, vertical
compression with
sliding plasty, P2
neochordae
C-E Physio II 32 mm Shortening of P2
neochordae and
addition of chordal
transfer
Yes
5 Fibroelastic deficiency P3 chordal elongation Chordal transfer to P3 and
placement of
neochordae to P3
C-E Physio 30 mm Short neochordae to P2
and P3 to shorten leaflet
height, magic suture to
anterior commissure
Yes
6 Fibroelastic deficiency P2 ruptured chord P2 triangular resection C-E Physio 26 mm Short neochordae to P2 Yes
Pt. no., Patient number; SAM, systolic anterior motion; C-E Physio, Carpentier-Edwards Physio Ring (Edwards Life Sciences, Irvine, Calif).
Mitral Valve Prolapse Varghese et alimportant to note that the medical management of SAM in-
traoperatively should not include nonphysiologic parame-
ters such as extreme bradycardia (heart rate< 45 beats/
min) or severe hypertension (mean arterial pressure>100
mm Hg) because although they might resolve SAM in the
operating room, the condition will likely return once the pa-
tient is ambulatory and no longer receiving vasoconstrictors
but instead oral b-blockers. A more difficult situation arises
when SAM (either mild or significant) persists after medical
therapies have been instituted in the operating room. The
surgeon must balance a number of factors when deciding
whether to re-arrest the heart and address the SAM by re-
repairing the valve. A number of factors come into play
when making this decision. We have sought to provide
some clarity to this decision making by presenting our algo-
rithm for the management of SAM and our results with in-
stituting it at our center. Our SAM incidence of 6.6% is
similar to that published by other groups.1,2 This
algorithm provides focused guidance on managing SAM
intraoperatively and postoperatively. We must stress the
importance of a technically adequate repair at the outset.
Ensuring a posterior leaflet height of less than 15 mm,
ensuring a posterior displaced closure line, and avoiding
an undersized annuloplasty ring are key elements to
minimizing the incidence of SAM. Furthermore, being
cognizant of the risk factors for SAM as previously
mentioned can change one’s repair strategy at the outset
(eg, using a sliding plasty). Although significant SAM canS6 The Journal of Thoracic and Cardiovascular Surgeresolve intraoperatively, it can—as we have shown—recur
in the postoperative period. Hence, we advocate ‘‘targeted
postoperative care’’ for patients with intraoperative SAM
that improved with medical therapy, hence minimizing
the incidence of recurrent SAM. We found that
postoperative SAM that recurred (after resolving
intraoperatively) always resolved with medical therapy
and did not require surgical intervention. We advocate an
immediate intervention strategy for patients who have
significant SAM intraoperatively that does not resolve
with intraoperative medical therapy. Some might argue
that re-arresting the heart and the prolonged bypass time
puts patients at increased surgical risk. However, we would
argue that the repair technique required for SAM often can
be done with 1 dose of cardioplegia, without removing the
annuoplasty ring and just addressing the posterior leaflet
height. Furthermore, the treatment of a patient in the post-
operative period with myocardial dysfunction requiring
inotropic support is challenging if SAM persists. It is impor-
tant to note that all cases of intraoperative SAM do not re-
solve with medical management. Zegdi and colleagues10
reported a case of SAM after MVRr in a symptomatic pa-
tient who required repeat repair 8 years after the initial sur-
gery. We have also had 1 case of mitral valve re-repair for
SAM in a 50-year-old patient who developed New York
Heart Association class II symptoms secondary to SAM
with moderate MR and a LVOT gradient of 90 mm Hg on
exercise. He had undergoneMVRr 5 years earlier at anotherry c April 2012
Varghese et al Mitral Valve Prolapseinstitution. Given these findings, an aggressive, but strate-
gic, approach to SAM should be undertaken.
In our series, we found 11 (21.2%) of 52 new cases of
SAM postoperatively. These were patients in whom SAM
was not reported intraoperatively.We believe this can be ex-
plained by dynamic changes in left ventricular function dur-
ing the postoperative period. Myocardial stunning, which
was present intraoperatively, might have resolved and the
increased ventricular function in the presence of an under-
filled ventricle might have led to SAM. In all cases of
new postoperative SAM, medical management was ade-
quate at leading to resolution. In 2 cases of new postopera-
tive SAM, the LVOT gradients were measured at greater
than 50 mm Hg. Both of these patients had hyperdynamic
left ventricles with an ejection fraction of 70% or greater
postoperatively. In these 2 asymptomatic younger patients,
we elected to continue medical therapy and allow their ven-
tricles time to return to normal, which led to resolution of
the SAM.
A number of surgical methods have been suggested
for addressing SAM.11-14 All have the same goals of
addressing the excessive posterior leaflet tissue and
migrating the leaflet closure line toward the posterior
annulus and hence addressing the mismatch between the
mitral valve annular dimension and the amount of leaflet
tissue present. Although not explicitly stated in the
algorithm, mitral valve replacement for SAM is an option
to consider in instances in which repeat repair has failed
to alleviate SAM and the patient’s comorbidities or
operative duration warrant a timely resolution.
Our study had some limitations. The data were collected
in a retrospective fashion, and hence some cases of SAM
might have been missed. Echocardiograms were performed
by a number of different technicians and read by different
anesthesiologists and cardiologists, which may have led to
operator biases. Our long-term data were limited to
a mean of only 1.3 years; therefore, the long-term outcomes
of these patients in whom SAM has resolved is not known.The Journal of Thoracic and CaUsing this algorithm to address SAM in the perioperative
period, we hope to provide a more systematic, guided ap-
proach to the management of SAM with proven results
and solidify the value of an excellent technical repair to
minimize its risk at the outset.References
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